Mutations in the gene encoding ɛ-sarcoglycan cause myoclonus–dystonia syndrome
✍ Scribed by Zimprich, Alexander; Grabowski, Monika; Asmus, Friedrich; Naumann, Markus; Berg, Daniela; Bertram, Markus; Scheidtmann, Karl; Kern, Peter; Winkelmann, Juliane; Müller-Myhsok, Bertram; Riedel, Leonhard; Bauer, Matthias; Müller, Tanja; Castro, Mirna; Meitinger, Thomas; Strom, Tim M.; Gasser, Thomas
- Book ID
- 109919654
- Publisher
- Nature Publishing Group
- Year
- 2001
- Tongue
- English
- Weight
- 530 KB
- Volume
- 29
- Category
- Article
- ISSN
- 1061-4036
- DOI
- 10.1038/ng709
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Myoclonus-dystonia syndrome (MDS) is a non-degenerative neurological disorder that has been described to be inherited in an autosomal dominant mode with incomplete penetrance. MDS is caused by loss of function mutations in the epsilon-sarcoglycan gene. Reinvestigation of MDS pedigrees provided evide
## Abstract We describe two affected individuals in a family with myoclonus–dystonia syndrome complicated with severe depression. One individual committed suicide. Molecular genetic analysis revealed a heterozygous point mutation in the ε‐sarcoglycan gene, which we show leads to skipping of exon 5.